Authors: VAHDAT LT PAPADOPOULOS K BALMACEDA C MCGOVERN T DUNLEAVY J KAUFMAN E FUNG B GARRETT T SAVAGE D TIERSTEN A AYELLO J BAGIELLA E HEITJAN D ANTMAN K HESDORFFER C

Citation: Lt. Vahdat et al., PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH ESCALATING DOSE PACLITAXEL, MELPHALAN, AND CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH PERIPHERAL-BLOOD PROGENITOR SUPPORT IN WOMEN WITH RESPONDING METASTATIC BREAST-CANCER, Clinical cancer research, 4(7), 1998, pp. 1689-1695

Authors: PAPADOPOULOS KP GARVIN JH FETELL M VAHDAT LT GARRETT TJ SAVAGE DG BALMACEDA C BRUCE J SISTI M ISAACSON S DELAPAZ R HAWKS R BAGIELLA E ANTMAN KH HESDORFFER CS

Citation: Kp. Papadopoulos et al., HIGH-DOSE THIOTEPA AND ETOPOSIDE-BASED REGIMENS WITH AUTOLOGOUS HEMATOPOIETIC SUPPORT FOR HIGH-RISK OR RECURRENT CNS TUMORS IN CHILDREN ANDADULTS, Bone marrow transplantation, 22(7), 1998, pp. 661-667

Authors: PAPADOPOULOS KP AYELLO J TUGULEA S HEITJAN DF WILLIAMS C REISS RF VAHDAT LT SUCIUFOCA N ANTMAN KH HESDORFFER CS

Citation: Kp. Papadopoulos et al., HARVEST QUALITY AND FACTORS AFFECTING COLLECTION AND ENGRAFTMENT OF CD34-CANCER SCHEDULED FOR HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT( CELLS IN PATIENTS WITH BREAST), Journal of hematotherapy, 6(1), 1997, pp. 61-68

Authors: GARRETT TJ VAHDAT LT KINNE DW

Citation: Tj. Garrett et al., SYSTEMIC ADJUVANT THERAPY OF BREAST-CANCER, Journal of surgical oncology, 64(2), 1997, pp. 167-172

Authors: PAPADOPOULOS KP VAHDAT LT AYELLO J REISS RF ANTMAN KH HESDORFFER CS

Citation: Kp. Papadopoulos et al., PACLITAXEL (P) 825 MG M(2) MAY NOT REQUIRE STEM-CELL SUPPORT/, Blood, 90(10), 1997, pp. 4380-4380